Emma Walmsley

Andrew Palmer learns leadership lessons from CEO of GSK, Emma Walmsley; Nobel prize-winning psychologist, Daniel Kahneman; and one-time COO of Stripe, Claire Hughes-Johnson. Topics discussed include leadership experiments, defining company purpose, effective decision-making, being explicit as a manager, improving team performance, and reflections on leadership challenges.

In this engaging discussion, Emma Walmsley, CEO of GSK and a key player in pharmaceuticals, shares insights on drug discovery and the integration of AI in speeding up medical advancements. She highlights GSK's breakthroughs in cancer treatments and respiratory medicine, while tackling the challenges of drug pricing and access. Emma also emphasizes the need for culture change within companies to foster innovation and accountability, and the significance of curiosity in leadership. Tune in for a captivating look at the future of healthcare!

The podcast features Emma Walmsley, the CEO of GSK, Daniel Kahneman, a Nobel prize-winning psychologist, and Claire Hughes-Johnson, the one-time COO of Stripe. They discuss lessons in leadership outside the office, the importance of leadership and clarity, the value of being explicit as a manager, and the significance of stepping back and effective leadership.

Emma Walmsley, CEO of GSK and the most powerful woman in corporate Britain, shares her insights on transformative leadership. She emphasizes the importance of clear communication in defining a company’s purpose, especially in biopharma. Walmsley discusses overcoming imposter syndrome and aligning employee incentives with organizational goals. She highlights the value of humility and self-awareness in leadership, along with the need for effective meetings to foster a culture of accountability and innovation within teams.

Emma Walmsley, CEO of GSK and a leader in the pharmaceutical sector, shares fascinating insights on drug discovery and company culture. She discusses GSK's innovative advancements in cancer treatments and HIV therapies. Emma highlights the transformative role of AI in speeding up drug development. She emphasizes the importance of balancing drug accessibility and pricing, alongside the necessity of curiosity and partnership in navigating change. Tune in for her vision on reshaping healthcare for billions around the globe!